Use of isoxsuprine for treatment of clinical signs associated with presumptive atherosclerosis in a yellow-naped Amazon parrot (Amazona ochrocephala auropalliata).
A 35-year-old yellow-naped Amazon parrot (Amazona ochrocephala auropalliata) was presented for gradually increasing inappetence, ataxia, weakness, and lethargy. Radiographic and ultrasonographic findings were strongly suggestive of atherosclerosis. Isoxsuprine, a peripheral vasodilator demonstrated to be of benefit in humans with intermittent limb pain, weakness, and lameness secondary to occlusive vascular disease, was selected for treatment. The bird's clinical signs resolved during treatment but recurred after varying periods of time when the medication was stopped intermittently. Nearly 3 years after the initial examination, the parrot was doing well on isoxsuprine therapy, with normal prehension of food with its feet and no recurrence of clinical signs.
Simone-Freilicher
Elisabeth
E
Veterinary Medical Center of Long Island, 75 Sunrise Highway, West Islip, NY 11795, USA.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001715:Bird Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000662:veterinary*; D003937:Diagnosis, Differential; D005260:Female; D007556:Isoxsuprine / Q000008:administration & dosage / Q000627:therapeutic use*; D010311:Parrots; D011859:Radiography
D000318:Adrenergic beta-Agonists; D007556:Isoxsuprine